3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Gynecologic
1
Gastrointestinal
1
Dermatologic
1
Conditions
Colorectal Neoplasms
105
Carcinoma, Hepatocellular
34
Gastrointestinal Stromal Tumors
17
Colonic Neoplasms
14
Rectal Neoplasms
12
Neoplasm Metastasis
12
Liver Neoplasms
8
Stomach Neoplasms
5
Cholangiocarcinoma
5
Pancreatic Neoplasms
4
Esophageal Neoplasms
4
Sarcoma
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Colorectal Cancer Metastatic
3
Carcinoma, Renal Cell
3
Advanced Colorectal Cancer
3
Squamous Cell Carcinoma of Head and Neck
2
Small Cell Lung Carcinoma
2
Neoplasms
2
Mesothelioma, Malignant
2
Melanoma
2
Lung Neoplasms
2
Glioblastoma
2
Gastrointestinal Neoplasms
2
Gallbladder Neoplasms
2
Fatigue
2
Esophageal Squamous Cell Carcinoma
2
Colorectal Cancer Liver Metastases
2
Carcinoma, Transitional Cell
2
Carcinoma, Non-Small-Cell Lung
2
Interventions
Cyclophosphamide
2
Celecoxib
2
zimberelimab
1
regorafenib
1
pembrolizumab
1
fludarabine
1
entinostat
1
anetumab ravtansine
1
Psychiatric Rehabilitation
1
Gemcitabine
1
Fentanyl
1
FANG vaccine
1
Early Intervention, Educational
1
Doxepin
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Thymoma
×
regorafenib
×
Gastrointestinal
×
Clear all
NCT02307500
2022-09-10
RESOUND
Istituto Clinico Humanitas
Phase 2
Completed
82 enrolled